Webinar Date: 7/31/2024
Time: 1pm ET, 10am PT
Join us for an insightful webinar aimed at biopharma, academic, and government researchers focused on reducing drug candidate translational failure and enhancing disease research. Discover the importance of predictive, human-relevant models in drug discovery and development, and learn why many researchers are turning to Organ-Chips for deeper insights into disease mechanisms and drug safety assessments.
Luke Dimasi, Senior Director of Product Management at Emulate, will provide an overview of microphysiological systems and explain how Organ-Chips integrate into the drug discovery and development process. Gautam Mahajan, Ph.D., Emulate Principal Scientific Lead, will present data-driven case studies where Organ-Chips successfully provided researchers with human-relevant insights into inflammatory & infectious disease mechanisms as well as drug candidate safety and efficacy.
Whether you are new to Organ-on-a-Chip technology or looking to deepen your expertise, this webinar will equip you with the knowledge and insights needed to integrate this advanced technology into your research.
You will hear about:
- An introduction to microphysiological systems (MPS): Understand the use cases, benefits, and differences between spheroids, organoids, and Organ-Chips.
- Endpoint analysis: Learn how to perform rich multi-modal endpoint assessments with Organ-Chips, including imaging, effluent, -omics, and immuno-phenotyping analyses.
- Case studies and success stories: Hear real-world examples of how Organ-Chips have provided more human-relevant insights into disease research and drug development.
Who should attend:
- Academic life science researchers (early discovery)
- Disease researchers (early discovery)
- Biotech & pharmaceutical preclinical researchers (lead optimization)
- Toxicologists (preclinical safety)